ARIAD selects Biolgics to be exclusive specialty pharmacy provider for Iclusig Biologics has been selected by ARIAD Pharmaceuticals to be the sole specialty pharmacy provider of Iclusig and manager of its Patient Access and Support Services program. Iclusig is a treatment for adult patients with refractory chronic myeloid leukemia or Philadelphia-chromosome positive acute lymphoblastic leukemia. The decision by ARIAD to utilize a closed distribution network with Biologics was made to ensure a high-touch care model for patients on Iclusig and to increase efficiencies as the product is made commercially available in the U.S. this month.
News For ARIA From The Last 14 Days
Check below for free stories on ARIA the last two weeks.